dc.contributor.author | Cantez, S | |
dc.contributor.author | Adalet, I | |
dc.contributor.author | Demirkale, P | |
dc.contributor.author | Unal, S | |
dc.contributor.author | Ouz, H | |
dc.contributor.author | Alagol, F | |
dc.date.accessioned | 2022-02-18T11:26:31Z | |
dc.date.available | 2022-02-18T11:26:31Z | |
dc.date.issued | 1999 | |
dc.identifier.citation | Adalet I., Demirkale P., Unal S., Ouz H., Alagol F., Cantez S., "Disappointing results with Tc-99m tetrofosmin for detecting medullary thyroid carcinoma metastases comparison with Tc-99m VDMSA and TI-201", CLINICAL NUCLEAR MEDICINE, cilt.24, sa.9, ss.678-683, 1999 | |
dc.identifier.issn | 0363-9762 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_f7daa960-a673-4dbc-b04e-60ffb3fcc1c1 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/181198 | |
dc.identifier.uri | https://doi.org/10.1097/00003072-199909000-00008 | |
dc.description.abstract | Purpose: This prospective study assessed the detectability of metastatic lesions by Tc-99m tetrofosmin in medullary thyroid carcinoma and to compare the results with Tc-99m penta dimercapto succinic acid (VDMSA) and Tl-201. | |
dc.language.iso | eng | |
dc.subject | Tıp | |
dc.subject | RADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Nükleer Tıp | |
dc.subject | Radiology, Nuclear Medicine and Imaging | |
dc.subject | Radiological and Ultrasound Technology | |
dc.subject | Health Sciences | |
dc.title | Disappointing results with Tc-99m tetrofosmin for detecting medullary thyroid carcinoma metastases comparison with Tc-99m VDMSA and TI-201 | |
dc.type | Makale | |
dc.relation.journal | CLINICAL NUCLEAR MEDICINE | |
dc.contributor.department | , , | |
dc.identifier.volume | 24 | |
dc.identifier.issue | 9 | |
dc.identifier.startpage | 678 | |
dc.identifier.endpage | 683 | |
dc.contributor.firstauthorID | 3371615 | |